contact header image 1
line
 

Coya’s focus is on generating safe, tolerable, and efficacious therapeutics that minimally burden the patient and caregiver and exponentially improve outcomes over the current standard of care

 
tech01

Clinical Trials

Check back regularly for updates on upcoming trials.

CLINICALTRIALS.GOV





Advocacy groups

We hope you'll find guidance through the numerous advocacy groups who offer valuable education and support to individuals, and their families, diagnosed with neurodegenerative disorders.
  • alzh
  • alzh
  • alzh
  • alzh
  • alzh
  • alzh